A Food & Drug Administration (FDA) warning letter says that Medtronic Inc. waited too long to issue a recall of its SynchroMed II Drug Pumps, and did not respond properly to reports of problems with MiniMed Paradigm Insulin Pump.
The FDA warning letter stemmed from an inspection of Medtronic’s Puerto Rican facility where the pumps are made that occurred from November 12, 2008 through December 15, 2008. The company has 15 working days from the date it received the warning letter to respond to the FDA. The FDA letter warned Medtronic that failure to promptly correct violations could result in regulatory action being initiated without further notice. (more…)

